300030 Stock Overview
Engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Improve Medical Instruments Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.58 |
| 52 Week High | CN¥8.30 |
| 52 Week Low | CN¥3.31 |
| Beta | 0.34 |
| 1 Month Change | -2.23% |
| 3 Month Change | 21.40% |
| 1 Year Change | -15.96% |
| 3 Year Change | -31.95% |
| 5 Year Change | -10.11% |
| Change since IPO | -22.57% |
Recent News & Updates
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Oct 28
Improve Medical Instruments Co., Ltd. (SZSE:300030) Held Back By Insufficient Growth Even After Shares Climb 46%
Sep 10Recent updates
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Oct 28Improve Medical Instruments Co., Ltd. (SZSE:300030) Held Back By Insufficient Growth Even After Shares Climb 46%
Sep 10Revenues Working Against Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Share Price Following 26% Dive
Jun 06A Look At The Fair Value Of Improve Medical Instruments Co., Ltd. (SZSE:300030)
Jun 04Benign Growth For Improve Medical Instruments Co., Ltd. (SZSE:300030) Underpins Stock's 27% Plummet
Apr 16Improve Medical Instruments Co., Ltd.'s (SZSE:300030) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 26Shareholder Returns
| 300030 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -6.4% | -1.5% | -1.2% |
| 1Y | -16.0% | -18.1% | 11.8% |
Return vs Industry: 300030 exceeded the CN Life Sciences industry which returned -18.1% over the past year.
Return vs Market: 300030 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 300030 volatility | |
|---|---|
| 300030 Average Weekly Movement | 12.1% |
| Life Sciences Industry Average Movement | 10.1% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300030's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300030's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 936 | Guanhua Deng | www.improve-medical.com |
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample needles, blood collection sets, tourniquets and disposable tourniquets, urine collection systems, and holders under IMPROVACUTER brand name; and IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, IMPROSAFE safety blood collection needles, IMPROSWAB microbiological transport swabs, IMPROVE sharps containers, liquid biopsy pre-analytical systems, etc. In addition, it provides clinical nursing products, including automatic, handheld, pulsewave, and smart wireless blood pressure monitors; and intelligent management solutions, such as blood collection tube preparation systems, friendly graphic user interfaces, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels, as well as CryoMax vials and liquid nitrogen freezing storage boxes.
Improve Medical Instruments Co., Ltd. Fundamentals Summary
| 300030 fundamental statistics | |
|---|---|
| Market cap | CN¥2.03b |
| Earnings (TTM) | -CN¥108.91m |
| Revenue (TTM) | CN¥593.69m |
3.4x
P/S Ratio-18.7x
P/E RatioIs 300030 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300030 income statement (TTM) | |
|---|---|
| Revenue | CN¥593.69m |
| Cost of Revenue | CN¥377.55m |
| Gross Profit | CN¥216.14m |
| Other Expenses | CN¥325.05m |
| Earnings | -CN¥108.91m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.35 |
| Gross Margin | 36.41% |
| Net Profit Margin | -18.34% |
| Debt/Equity Ratio | 53.1% |
How did 300030 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Improve Medical Instruments Co., Ltd. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| YANG QIAO | Changjiang Securities Co. LTD. |
| Wenxin Yu | China Investment Securities |
| Yaming Liu | Founder Securities Co., Ltd. |